159 related articles for article (PubMed ID: 8834030)
1. Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study.
Ikeda T; Tozuka S; Noguchi O; Kobayashi F; Sakamoto S; Marumo F; Sato C
J Hepatol; 1996 Jan; 24(1):88-94. PubMed ID: 8834030
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid.
Vuoristo M; Färkkilä M; Karvonen AL; Leino R; Lehtola J; Mäkinen J; Mattila J; Friman C; Seppälä K; Tuominen J
Gastroenterology; 1995 May; 108(5):1470-8. PubMed ID: 7729640
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
[TBL] [Abstract][Full Text] [Related]
4. Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis.
Almasio PL; Floreani A; Chiaramonte M; Provenzano G; Battezzati P; Crosignani A; Podda M; Todros L; Rosina F; Saccoccio G; Manenti F; Ballardini G; Bianchi FP; Scheuer PJ; Davies SE; Craxì A
Aliment Pharmacol Ther; 2000 Dec; 14(12):1645-52. PubMed ID: 11121914
[TBL] [Abstract][Full Text] [Related]
5. Bezafibrate for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Jan; 1():CD009145. PubMed ID: 22259000
[TBL] [Abstract][Full Text] [Related]
6. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial.
Angulo P; Dickson ER; Therneau TM; Jorgensen RA; Smith C; DeSotel CK; Lange SM; Anderson ML; Mahoney DW; Lindor KD
J Hepatol; 1999 May; 30(5):830-5. PubMed ID: 10365809
[TBL] [Abstract][Full Text] [Related]
8. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol.
Bonis PA; Kaplan M
Gastroenterology; 1999 Aug; 117(2):395-9. PubMed ID: 10419921
[TBL] [Abstract][Full Text] [Related]
10. A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis.
Oka H; Toda G; Ikeda Y; Hashimoto N; Hasumura Y; Kamimura T; Ohta Y; Tsuji T; Hattori N; Namihisa T
Gastroenterol Jpn; 1990 Dec; 25(6):774-80. PubMed ID: 1980654
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid.
Kaplan MM; Bonder A; Ruthazer R; Bonis PA
Dig Dis Sci; 2010 Nov; 55(11):3207-17. PubMed ID: 20559727
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Balkau B; Eschwège E; Poupon R
N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
[TBL] [Abstract][Full Text] [Related]
13. Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone.
Buscher HP; Zietzschmann Y; Gerok W
J Hepatol; 1993 Apr; 18(1):9-14. PubMed ID: 8101853
[TBL] [Abstract][Full Text] [Related]
14. Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis.
Roda E; Azzaroli F; Nigro G; Piazza F; Jaboli F; Ferrara F; Liva S; Giovanelli S; Miracolo A; Colecchia A; Festi D; Mazzeo C; Bacchi L; Roda A; Mazzella G
Dig Liver Dis; 2002 Jul; 34(7):523-7. PubMed ID: 12236487
[TBL] [Abstract][Full Text] [Related]
15. Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study.
Wolfhagen FH; van Hoogstraten HJ; van Buuren HR; van Berge-Henegouwen GP; ten Kate FJ; Hop WC; van der Hoek EW; Kerbert MJ; van Lijf HH; den Ouden JW; Smit AM; de Vries RA; van Zanten RA; Schalm SW
J Hepatol; 1998 Nov; 29(5):736-42. PubMed ID: 9833911
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid treatment in a patient with primary biliary cirrhosis.
Wouters RS; Bos LP; Engels LG
Neth J Med; 1990 Aug; 37(1-2):21-3. PubMed ID: 2215828
[TBL] [Abstract][Full Text] [Related]
17. Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment.
Kaplan MM; DeLellis RA; Wolfe HJ
Ann Intern Med; 1997 May; 126(9):682-8. PubMed ID: 9139553
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.
Poupon RE; Eschwège E; Poupon R
J Hepatol; 1990 Jul; 11(1):16-21. PubMed ID: 1975819
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
Wolfhagen FH; van Buuren HR; Schalm SW
Neth J Med; 1994 Mar; 44(3):84-90. PubMed ID: 8202208
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study.
Nakai S; Masaki T; Kurokohchi K; Deguchi A; Nishioka M
Am J Gastroenterol; 2000 Jan; 95(1):326-7. PubMed ID: 10638623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
